213 related articles for article (PubMed ID: 33571505)
1. Higher susceptibility to heme oxidation and lower protein stability of the rare α
Sharina I; Lezgyieva K; Krutsenko Y; Martin E
Biochem Pharmacol; 2021 Apr; 186():114459. PubMed ID: 33571505
[TBL] [Abstract][Full Text] [Related]
2. BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugs.
Sömmer A; Sandner P; Behrends S
Biochem Pharmacol; 2018 Jan; 147():10-20. PubMed ID: 29155144
[TBL] [Abstract][Full Text] [Related]
3. Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants.
Wobst J; von Ameln S; Wolf B; Wierer M; Dang TA; Sager HB; Tennstedt S; Hengstenberg C; Koesling D; Friebe A; Braun SL; Erdmann J; Schunkert H; Kessler T
Basic Res Cardiol; 2016 Jul; 111(4):51. PubMed ID: 27342234
[TBL] [Abstract][Full Text] [Related]
4. The Role of Reactive Oxygen and Nitrogen Species in the Expression and Splicing of Nitric Oxide Receptor.
Sharina IG; Martin E
Antioxid Redox Signal; 2017 Jan; 26(3):122-136. PubMed ID: 26972233
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
[TBL] [Abstract][Full Text] [Related]
6. Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.
Zhou Z; Pyriochou A; Kotanidou A; Dalkas G; van Eickels M; Spyroulias G; Roussos C; Papapetropoulos A
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1763-71. PubMed ID: 18757489
[TBL] [Abstract][Full Text] [Related]
7. Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide.
Zhou Z; Martin E; Sharina I; Esposito I; Szabo C; Bucci M; Cirino G; Papapetropoulos A
Pharmacol Res; 2016 Sep; 111():556-562. PubMed ID: 27378567
[TBL] [Abstract][Full Text] [Related]
8. Targeting heme-oxidized soluble guanylate cyclase to promote osteoblast function.
Tesfamariam B
Drug Discov Today; 2020 Feb; 25(2):422-429. PubMed ID: 31846712
[TBL] [Abstract][Full Text] [Related]
9. Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor.
Beuve A
Antioxid Redox Signal; 2017 Jan; 26(3):137-149. PubMed ID: 26906466
[TBL] [Abstract][Full Text] [Related]
10. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
[TBL] [Abstract][Full Text] [Related]
11. Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats.
Hoffmann LS; Kretschmer A; Lawrenz B; Hocher B; Stasch JP
PLoS One; 2015; 10(12):e0145048. PubMed ID: 26717150
[TBL] [Abstract][Full Text] [Related]
12. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
[TBL] [Abstract][Full Text] [Related]
13. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
[TBL] [Abstract][Full Text] [Related]
14. Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
Hervé D; Philippi A; Belbouab R; Zerah M; Chabrier S; Collardeau-Frachon S; Bergametti F; Essongue A; Berrou E; Krivosic V; Sainte-Rose C; Houdart E; Adam F; Billiemaz K; Lebret M; Roman S; Passemard S; Boulday G; Delaforge A; Guey S; Dray X; Chabriat H; Brouckaert P; Bryckaert M; Tournier-Lasserve E
Am J Hum Genet; 2014 Mar; 94(3):385-94. PubMed ID: 24581742
[TBL] [Abstract][Full Text] [Related]
15. Role of soluble guanylyl cyclase in renal afferent and efferent arterioles.
Wennysia IC; Zhao L; Schomber T; Braun D; Golz S; Summer H; Benardeau A; Lai EY; Lichtenberger FB; Schubert R; Persson PB; Xu MZ; Patzak A
Am J Physiol Renal Physiol; 2021 Feb; 320(2):F193-F202. PubMed ID: 33356952
[TBL] [Abstract][Full Text] [Related]
16. Synergistic stabilisation of NOsGC by cinaciguat and non-hydrolysable nucleotides: Evidence for sGC activator-induced communication between the heme-binding and catalytic domains.
Sömmer A; Behrends S
Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):702-711. PubMed ID: 29653192
[TBL] [Abstract][Full Text] [Related]
17. Dental Pulp Inflammation Initiates the Occurrence of Mast Cells Expressing the α
Korkmaz Y; Plomann M; Puladi B; Demirbas A; Bloch W; Deschner J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674416
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE.
Sürmeli NB; Müskens FM; Marletta MA
J Biol Chem; 2015 Jun; 290(25):15570-15580. PubMed ID: 25907555
[TBL] [Abstract][Full Text] [Related]
19. Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.
Guey S; Hervé D; Kossorotoff M; Ha G; Aloui C; Bergametti F; Arnould M; Guenou H; Hadjadj J; Dubois Teklali F; Riant F; Balligand JL; Uzan G; Villoutreix BO; Tournier-Lasserve E
Hum Genomics; 2023 Mar; 17(1):24. PubMed ID: 36941667
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
Hoffmann LS; Schmidt PM; Keim Y; Hoffmann C; Schmidt HH; Stasch JP
PLoS One; 2011; 6(8):e23596. PubMed ID: 21858179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
